Does Trintellix Cause Night Sweats?
Yes, Trintellix (vortioxetine) can cause night sweats as it belongs to the SSRI class of antidepressants, which are recognized pharmaceutical causes of sweating. 1, 2
Evidence for SSRI-Induced Sweating
The Endocrine Society Clinical Practice Guideline explicitly lists SSRIs as a pharmaceutical cause of sweats in their differential diagnosis table for vasomotor symptoms 1. The FDA label for Trintellix lists sweating as a potential side effect, particularly in the context of serotonin syndrome and discontinuation syndrome 2. While "night sweats" is not specifically itemized as a standalone adverse effect in the FDA label, sweating is clearly documented as occurring with this medication.
Differentiating Drug-Induced vs. Menopausal Night Sweats
Timing is Critical
The key differentiating factor is temporal relationship: drug-induced sweating typically begins within days to weeks after starting the medication, whereas menopausal vasomotor symptoms usually predate medication initiation or have been ongoing. 1, 3
Clinical Characteristics to Assess
Menopausal night sweats 1:
- Begin with sudden sensation of heat centered on upper chest and face
- Rapidly become generalized when moderate-to-severe
- Last 2-4 minutes per episode
- Associated with profuse perspiration, palpitations, or anxiety
- More common during first 4 hours of sleep
- May have triggers (spicy food, alcohol)
- Often accompanied by daytime hot flashes
SSRI-induced sweating 4:
- Can occur primarily on head and back of neck (though can be generalized)
- May be more continuous or frequent rather than discrete 2-4 minute episodes
- Typically not preceded by sensation of heat/flushing
- Less likely to have specific triggers like food or alcohol
- May occur throughout the night rather than clustering in first 4 hours
Diagnostic Algorithm
Establish baseline symptom timeline: Did night sweats exist before starting Trintellix? If yes, likely menopausal. If they started within 1-8 weeks of initiating Trintellix, suspect drug-induced component 4.
Assess symptom pattern:
Check for daytime hot flashes: Presence strongly suggests menopausal etiology, as approximately 75% of perimenopausal women experience these 1
Consider a therapeutic trial: If symptoms are new or worsened since starting Trintellix and are bothersome:
Common Pitfall to Avoid
Do not assume all night sweats in a perimenopausal woman are menopausal. The guideline specifically warns that SSRIs cause sweats 1, and this can be overlooked when a woman is in the expected age range for menopause. Both etiologies can coexist, potentially requiring management of both the depression and vasomotor symptoms.
Management Considerations
If drug-induced sweating is confirmed or suspected 4:
- Consider dose reduction of Trintellix
- If ineffective, consider switching to a different antidepressant class
- Adjunctive agents like benztropine or cyproheptadine can treat sweating symptoms if antidepressant cannot be changed
If menopausal etiology is confirmed 1:
- Hormone therapy is most effective for vasomotor symptoms
- Interestingly, one preliminary study showed vortioxetine itself improved hot flash frequency and severity in perimenopausal women with depression 5, though this requires further validation
The presence of both conditions simultaneously is possible and may require addressing both the antidepressant choice and menopausal symptoms independently.